Download PDF
Thromb Haemost 1976; 36(03): 551-565
DOI: 10.1055/s-0038-1648076
Original Article
Schattauer GmbH

On the Reliability of Plasminogen Measurement Employing the Proactivator-Activator Converting Method

M Martin
1   Aggertalklinik, Clinic for Vascular Diseases, Engelskirchen-Cologne, Germany
,
Technical Assistance,
Miss H Auel
1   Aggertalklinik, Clinic for Vascular Diseases, Engelskirchen-Cologne, Germany
› Author Affiliations
Further Information

Publication History

Received 12 December 1975

Accepted 28 July 1976

Publication Date:
24 July 2018 (online)

    Permissions and Reprints

Summary

A simple plasminogen determination method is presented. It is based upon the conversion of plasminogen into activator by large and constant amounts of streptokinase. The activator contained in a standard coagulum consisting of bovine fibrin, streptokinase, and a 1:40 dilution of human plasma converts the plasminogen adsorbed on bovine fibrin into plasmin. Lysis of the test coagulum is hereby induced. The speed of such lysis is limited by the concentration of the activator incorporated in the test coagulum. The variable component of the activator being human plasminogen, the speed of lysis is directly dependent upon the concentration of human plasminogen in the standard coagulum. Using the thromboelastograph according to Hartert in recording the test clot lysis times, this method of plasminogen determination was shown to be a simple and quick procedure. The standard deviation ranged from ± 13.2 to 68 %, depending upon the plasminogen value to be measured (lower rates of error were attached to high, and higher rates of error to low, plasminogen concentrations). The biological variation of plasminogen values in a group of 26 men aged from 40 to 65 years was calculated to be ±21 %. Both plasminogen and plasmin, its activated form, were exchangeable in the test, i.e. plasminogen determinations performed by activator assay did not differentiate between plasminogen and plasmin. There was no influence by varying anti-SK titers in the plasma up to a circulating antibody content of 2 million. Furthermore, plasma antiplasmins did not affect the plasminogen measuring system. Plasminogen tested by activator assay displayed values closely related to those achieved by immunochemical methods. Plasminogen measurements were performed in patients undergoing streptokinase and urokinase infusion treatment. 5,000 u streptokinase per hour, as well as 270,000 CTA-u urokinase per hour, infused over a period of 2 days produced a fall in plasminogen down to 30-60% of normal. In contrast, 100,000 u streptokinase per hour lowered the plasminogen concentration down to values of below 1%. The foregoing data indicate that plasminogen measurement, according to the principles outlined here (activator assay), may be regarded as a valuable and rehable method for the routine control of streptokinase and urokinase therapy.

 

  • References

  • 1 Auel H, Martin M. 1974; Plasminogengehalt eines im Handel befindlichen Rinderfibrinogens. Zeitschrift für Klinische Chemie und Klinische Biochemie 12: 385.
    PubMedGoogle Scholar
  • 2 Blix S. 1964; The proactivator (plasminogen?) determination in plasma during fibrinolytic therapy. Acta medica scandinavica 176: 649.
    PubMedGoogle Scholar
  • 3 Bruhn H. D, Müller L, Duckert F. 1970; Quantitative determination of plasminogen. A caseinolytic method. Thrombosis et Diathesis Haemorrhagica 23: 191.
    PubMedGoogle Scholar
  • 4 Christensen L. R. 1949; Methods for measuring the activity of components of the streptococcal fibrinolytic system, and streptococcal desoxyribonuclease. Journal of Clinical Investigation 28: 163.
    CrossrefPubMedGoogle Scholar
  • 5 Davies M. C, Englebert M. E, de Renzo E. C. 1964; Interaction of streptokinase and human plasminogen. I. Combining of streptokinase and human plasminogen observed in the ultracentrifuge under a variety of experimental conditions. Journal of Biological Chemistry 239: 2651.
    PubMedGoogle Scholar
  • 6 Elsner P. 1957; Fibrinolyse in Schwangerschaft und Geburt. Fortschritte der Geburtsheilkunde u. Gynäkologie 6: 1.
    PubMedGoogle Scholar
  • 7 Fischer M. 1970; Verhalten menschlicher Plasmininhibitoren bei intravasal erhöhter fibrinolytischer Aktivität. Thrombosis et Diathesis Haemorrhagica 23: 513.
    PubMedGoogle Scholar
  • 8 Ganrot P. O, Niléhn J. E. 1968; Immunochemical determination of human plasminogen. Clinica chemica Acta 22: 335.
    CrossrefPubMedGoogle Scholar
  • 9 Hartert H. 1951; Die Thromboelastographie. Eine Methode zur physikalischen Analyse des Blutgerinnungsvorgangs. Zeitschrift für die Gesamte Experimentelle Medizin 117: 189.
    CrossrefPubMedGoogle Scholar
  • 10 Heimburger N, Schwick G. 1962; Die Fibrinagar-Elektrophorese. 2. Mitteilung: Untersuchung zum Wirkungsmechanismus der Streptokinase. Thrombosis et Diathesis Haemorrhagica 7: 444.
    PubMedGoogle Scholar
  • 11 Hummel B. C. W, Buck F. F, de Renzo E. C. 1966; Interaction of streptokinase and human plasminogen. III. Plasmin and activator activities in reaction mixtures of streptokinase and human plasminogen or human plasmin of various molar ratios. Journal of Biological Chemistry 441: 3474.
    PubMedGoogle Scholar
  • 12 Johnson A. J, Tillet W. S. 1952; The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). Journal of Experimental Medicine 95: 449.
    CrossrefPubMedGoogle Scholar
  • 13 von Kaulla K. N, McDonald T. S. 1958; The effect of heparin on components of the human fibrinolytic system. Blood 13: 811.
    PubMedGoogle Scholar
  • 14 Kline D. L, Fishman J. B. 1957; Plasmin: The humoral protease. Annals of the New York Academy of Sciences 68: 25.
    CrossrefPubMedGoogle Scholar
  • 15 Lassen M. 1952; Heat denaturisation of plasminogen in the fibrinplate method. Acta physica scandinavica 27: 371.
    PubMedGoogle Scholar
  • 16 Ling C. M, Summaria L, Robbins K. C. 1965; Mechanism of formation of bovine plasminogen activator from human plasmin. Journal of Biological Chemistry 240: 4213.
    PubMedGoogle Scholar
  • 17 Loomis E. C. 1955. Estimation of fibrinolysin activity of human plasma or serum, 163-164. In Tocantis L. M. (Ed.): The Coagulation of Blood. Grune and Stratton; New York:
    Google Scholar
  • 18 Mancini G, Carbonara A. O, Heremans J. F. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235.
    CrossrefPubMedGoogle Scholar
  • 19 Martin M. 1969; Semiquantitative Plasminogenbestimmung mit Hilfe des Thrombelastographen. Eine Methode zur Kontrolle der Streptokinasebehandlung. Thrombosis et Diathesis Haemorrhagica (Stuttg.) 22: 121.
    PubMedGoogle Scholar
  • 20 Martin M. 1974; Indirect measurement of streptokinase concentration in the plasma of patients undergoing fibrinolytic treatment. Thrombosis et Diathesis Haemorrhagica 32: 633.
    PubMedGoogle Scholar
  • 21 Martin M. 1975. The fibrinolytic effect of euglobulin fraction from human plasma before and after addition of an acid polysaccharide (SP54). 276-283 In von Kaulla K. N, Davidson J. F. (Eds.): Synthetic Fibrinolytic-thrombolytic agents; Chemical, Biochemical, Pharmacological, and Clinical Aspects. Charles C. Thomas, Publisher; Springfield, Illinois:
    Google Scholar
  • 22 Müllertz S. 1955; Formation and properties of activator of plasminogen and of human and bovine plasmin. Biochemical Journal 61: 424.
    CrossrefPubMedGoogle Scholar
  • 23 Nagenda K, Reddy N, Markus G. 1972; Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex. Journal of Biological Chemistry 247: 1683.
    PubMedGoogle Scholar
  • 24 Niléhn J. E, Ganrot P. O. 1967; Plasmin, plasmin inhibitors and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase. Scandinavian Journal of Clinical and Laboratory Investigation 20: 113.
    CrossrefPubMedGoogle Scholar
  • 25 Remmert L. F, Cohen P. P. 1949; Partial purification and properties of a proteolytic enzyme in human serum. Journal of Biological Chemistry 181: 431.
    PubMedGoogle Scholar
  • 26 de Renzo E. C. 1961; Chemistry of fibrinolysis. Thrombosis et Diathesis Haemorrhagica (Suppl. 01) VI: 134.
    PubMedGoogle Scholar
  • 27 de Renzo E. C, Boggiano E, Barg W. F, Buck F. F. 1967; Interaction of streptokinase and human plasminogen. IV. Further gel electrophoretic studies on the combination of streptokinase with human plasminogen or human plasmin. Journal of Biological Chemistry 242: 2428.
    PubMedGoogle Scholar
  • 28 Robbins K. C, Bernabe P, Arzadon L, Summaria L. 1973; NH2-Terminal sequences of mammalian plasminogens and plasmin S-Carboxymethyl Heavy (A) and Light (B) Chain Derivatives. A re-evaluation of the mechanism of activation of plasminogen. Journal of Biological Chemistry 248: 7242.
    PubMedGoogle Scholar
  • 29 Summaria L, Arzadon L, Bernabe P, Robbins K. C. 1974; The interaction of streptokinase with human, cat, dog, and rabbit plasminogen. Journal of Biological Chemistry 249: 4760.
    PubMedGoogle Scholar
  • 30 Summaria L, Ling C. M, Groskopf W. R, Robbins K. C. 1968; The active site of bovine plasminogen activator. Interaction of streptokinase with human plasminogen and plasmin. Journal of Biological Chemistry 243: 144.
    PubMedGoogle Scholar
  • 31 Takada A, Takada Y, Ambrus J. C. 1970; Streptokinase activatable proactivator of human and bovine plasminogen. Journal of Biological Chemistry 245: 6389.
    PubMedGoogle Scholar
  • 32 Taylor F. B, Beisswenger J. G. 1973; Identification of modified streptokinase as the activator of bovine and human plasminogen. Journal of Biological Chemistry 218: 1127.
    PubMedGoogle Scholar
  • 33 Ts’ao C. H, Kline D. L. 1969; Plasminogen activator formed by reaction of streptokinase with human plasminogen. Journal of Applied Physiology 26: 634.
    CrossrefPubMedGoogle Scholar
  • 34 Troll W, Sherry S, Wachman J. 1954; The action of plasmin on synthetic substrates. Journal of Biological Chemistry 208: 85.
    PubMedGoogle Scholar
  • 35 de Vreker R. A. 1965; A technique for routine evaluation of plasminogen in humans during streptokinase therapy. Acta haematologica (Basel) 34: 305.
    CrossrefPubMedGoogle Scholar